Toll-like receptor 3 (TLR3) (TLR3)

Toll-like receptor 3 (TLR3) is a critical transmembrane pattern recognition receptor primarily located in endosomal membranes, where it detects double-stranded RNA (dsRNA) associated with viral replication. Unlike other Toll-like receptors, TLR3 signals exclusively through the TRIF (TIR-domain-containing adapter-inducing interferon-β) pathway, leading to the activation of IRF3 and NF-κB transcription factors to produce antiviral interferons and cytokines. The 'FYW peptide' refers to a specific inhibitory sequence derived from the highly conserved Phenylalanine-Tyrosine-Tryptophan motif within the receptor's TIR domain, which is essential for adapter protein recruitment. In oncology, TLR3 agonists are utilized as vaccine adjuvants and immunotherapies to stimulate anti-tumor T-cell responses and induce immunogenic cell death. Conversely, synthetic peptides targeting the FYW motif are being investigated as therapeutic inhibitors to mitigate chronic inflammation and autoimmune responses caused by overactive TLR3 signaling. Dysregulation of TLR3 is also significantly implicated in the pathogenesis of viral infections, where genetic deficiencies are a known risk factor for life-threatening herpes simplex encephalitis.

Other names

CD283Toll-like receptor 3TLR3 FYW motif peptideTLR3-TIR derived peptide

TLR3 agonists mimic viral double-stranded RNA to activate the receptor, triggering the TRIF-dependent signaling pathway that induces Type I interferons and pro-inflammatory cytokines. Peptides derived from the FYW (Phenylalanine-Tyrosine-Tryptophan) motif in the TLR3 TIR domain act as competitive inhibitors by disrupting the recruitment of the TRIF adapter, thereby blocking pathological TLR3 signaling.